ADVFN - ニュース

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

銘柄名/コード:

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 03	Edgar (US Regulatory)	Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend]	NYSE:PRU	Prudential Financial Inc
2024/06/15	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ERESU	East Resources Acquisition Company
2024/06/15	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SCOR	comScore Inc
2024/06/15	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LTCN	Grayscale Litecoin Trust LTC (QX)
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:KORGW	KORE Group Holdings Inc (PK)
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:OC	Owens Corning Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BRLT	Brilliant Earth Group Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TTMI	TTM Technologies Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EH	EHang Holdings Ltd
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BZ	Kanzhun Ltd
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RCAT	Red Cat Holdings Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HBIO	Harvard Bioscience Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:WT	WisdomTree Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TMUS	T Mobile US Inc
2024/06/15	05 : 02	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:TNTTF	Toronto Dominion Bank (PK)
2024/06/15	05 : 02	PR Newswire (Canada)	K-Bro Declares June 2024 Dividend	TSX:KBL	K Bro Linen Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:IRON	Disc Medicine Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTRW	eFFECTOR Therapeutics Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:JILL	J Jill Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ADTX	Aditxt Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NDRA	ENDRA Life Sciences Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MASS	908 Devices Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PROK	ProKidney Corporation
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/06/15	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/06/15	05 : 01	GlobeNewswire Inc.	Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024	NASDAQ:GLPG	Galapagos NV
2024/06/15	05 : 01	GlobeNewswire Inc.	Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024	TG:GXE	Galapagos

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Euro

Verizon Communications

BNP Paribas (QX)

JP Morgan Chase

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約